| Item Type | Name |
|
Academic Article
|
Irinotecan/gemcitabine followed by twice-weekly gemcitabine/radiation in locally advanced pancreatic cancer.
|
|
Academic Article
|
Peritoneal carcinomatosis: what can we do about it?
|
|
Academic Article
|
Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma.
|
|
Academic Article
|
Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis from small bowel adenocarcinoma.
|
|
Academic Article
|
Appendiceal neoplasms with peritoneal dissemination: outcomes after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy.
|
|
Academic Article
|
Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: experience with 501 procedures.
|
|
Academic Article
|
Intraperitoneal hyperthermic chemotherapy using carboplatin: a phase I analysis in ovarian carcinoma.
|
|
Academic Article
|
Patterns of care analysis among women with ductal carcinoma in situ in North Carolina.
|
|
Academic Article
|
Treatment of in-transit metastases from Merkel cell carcinoma with isolated hyperthermic limb perfusion.
|
|
Academic Article
|
EXTRA--a multicenter phase II study of chemoradiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancer.
|
|
Academic Article
|
A phase I trial of oxaliplatin for intraperitoneal hyperthermic chemoperfusion for the treatment of peritoneal surface dissemination from colorectal and appendiceal cancers.
|
|
Academic Article
|
Quality of life and nutritional assessment in peritoneal surface malignancy (PSM): recommendations for care.
|
|
Academic Article
|
Peritoneal surface disease from colorectal cancer: comparison with the hepatic metastases surgical paradigm in optimally resected patients.
|
|
Academic Article
|
Intraperitoneal hyperthermic chemotherapy: an evolving paradigm for the treatment of peritoneal surface malignancies.
|
|
Academic Article
|
The current role of hyperthermic intraperitoneal chemotherapy for peritoneal dissemination of appendiceal tumors.
|
|
Academic Article
|
Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: non-colorectal indications.
|
|
Academic Article
|
Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for malignant peritoneal mesothelioma: mitomycin versus cisplatin.
|
|
Academic Article
|
Primary leiomyosarcoma of the inferior vena cava: a 2-institution analysis of outcomes.
|
|
Academic Article
|
Childbearing after hyperthermic intraperitoneal chemotherapy: results from an international survey.
|
|
Academic Article
|
Survival and quality of life following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colonic origin.
|
|
Academic Article
|
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for patients with peritoneal carcinomatosis secondary to urachal adenocarcinoma.
|
|
Academic Article
|
Patient rated outcomes and survivorship following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (CS?+?HIPEC).
|
|
Academic Article
|
A comparison of hematologic toxicity profiles after heated intraperitoneal chemotherapy with oxaliplatin and mitomycin C.
|
|
Academic Article
|
Outcomes of repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal surface malignancy.
|
|
Academic Article
|
Three cytotoxic drugs combined with pelvic radiation and as maintenance chemotherapy for patients with squamous cell carcinoma of the anus (SCCA): long-term follow-up of a phase II pilot study using 5-fluorouracil, mitomycin C and cisplatin.
|
|
Academic Article
|
Current status and future directions in appendiceal cancer with peritoneal dissemination.
|
|
Academic Article
|
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer.
|
|
Academic Article
|
Breast cancer recurrences in elderly patients after lumpectomy.
|
|
Academic Article
|
Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis.
|
|
Academic Article
|
Long-term survivorship and quality of life after cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis.
|
|
Academic Article
|
Problems of success and problems of failure: recurrent disease after cytoreductive surgery and intraperitoneal chemoperfusion.
|
|
Academic Article
|
Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancer.
|
|
Academic Article
|
Long-term results of local excision with and without chemoradiation for adenocarcinoma of the rectum.
|
|
Academic Article
|
Leiomyosarcoma of the inferior vena cava: surgical management and clinical results.
|
|
Academic Article
|
Phase II trial of induction gemcitabine/CPT-11 followed by a twice-weekly infusion of gemcitabine and concurrent external beam radiation for the treatment of locally advanced pancreatic cancer.
|
|
Academic Article
|
Intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: current status and future directions.
|
|
Academic Article
|
Monitoring health outcomes following cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis.
|
|
Academic Article
|
Pathologic complete response may not represent the optimal surrogate for survival after preoperative therapy for esophageal cancer.
|
|
Academic Article
|
Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07.
|
|
Academic Article
|
Cytomorphologic features of primary peritoneal mesothelioma in effusion, washing, and fine-needle aspiration biopsy specimens: examination of 49 cases at one institution, including post-intraperitoneal hyperthermic chemotherapy findings.
|
|
Academic Article
|
Survival and health outcomes after cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of appendiceal origin.
|
|
Academic Article
|
Outcomes associated with cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in colorectal cancer patients with peritoneal surface disease and hepatic metastases.
|
|
Academic Article
|
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancy: overview and rationale.
|
|
Academic Article
|
The role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for metastatic colorectal cancer with peritoneal surface disease.
|
|
Academic Article
|
Translation considerations for hyperthermic intraperitoneal chemotherapy.
|
|
Academic Article
|
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience.
|
|
Academic Article
|
Hyperthermic intraperitoneal chemotherapy in ovarian cancer: first report of the HYPER-O registry.
|
|
Academic Article
|
Outcomes of patients with esophageal cancer staged with [ยน8F]fluorodeoxyglucose positron emission tomography (FDG-PET): can postchemoradiotherapy FDG-PET predict the utility of resection?
|
|
Academic Article
|
Outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface dissemination from ovarian neoplasms.
|
|
Academic Article
|
A novel tumor-node-metastasis (TNM) staging system of diffuse malignant peritoneal mesothelioma using outcome analysis of a multi-institutional database*.
|
|
Academic Article
|
Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
|
|
Academic Article
|
Race and recurrence in women who undergo neoadjuvant chemotherapy for breast cancer.
|
|
Academic Article
|
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from rectal cancer.
|
|
Academic Article
|
Optimal timing of systemic therapy in resectable colorectal liver metastases.
|
|
Concept
|
Antineoplastic Combined Chemotherapy Protocols
|
|
Concept
|
Chemotherapy, Adjuvant
|
|
Concept
|
Drug Therapy, Combination
|
|
Concept
|
Chemotherapy, Cancer, Regional Perfusion
|
|
Academic Article
|
Splenectomy ameliorates hematologic toxicity of hyperthermic intraperitoneal chemotherapy.
|
|
Academic Article
|
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in peritoneal sarcomatosis.
|
|
Academic Article
|
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from small bowel adenocarcinoma.
|
|
Academic Article
|
Predicting postoperative morbidity following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CS+HIPEC) with preoperative FACT-C (Functional Assessment of Cancer Therapy) and patient-rated performance status.
|
|
Academic Article
|
Outcomes of Cytoreductive Surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients older than 70 years; survival benefit at considerable morbidity and mortality.
|
|
Academic Article
|
Definitive results of a phase III adjuvant trial comparing three chemotherapy regimens in women with operable, node-positive breast cancer: the NSABP B-38 trial.
|
|
Academic Article
|
Obesity and peritoneal surface disease: outcomes after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for appendiceal and colon primary tumors.
|
|
Academic Article
|
Peritoneal surface disease with synchronous hepatic involvement treated with Cytoreductive Surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
|
|
Academic Article
|
Impact of distal pancreatectomy on outcomes of peritoneal surface disease treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
|
|
Academic Article
|
Prospective Registry On Mesothelioma Peritonei Treatment (PROMPT): study design and rationale.
|
|
Academic Article
|
Efficacy of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in the management of malignant ascites.
|
|
Academic Article
|
Significance of urinary tract involvement in patients treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
|
|
Academic Article
|
Perioperative systemic chemotherapy for appendiceal mucinous carcinoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
|
|
Academic Article
|
Phase II trial of adjuvant oral thalidomide following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface disease from colorectal/appendiceal cancer.
|
|
Academic Article
|
Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients.
|
|
Academic Article
|
Metastatic colorectal cancer: survival comparison of hepatic resection versus cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
|
|
Academic Article
|
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for gallbladder cancer: a retrospective review.
|
|
Academic Article
|
Significance of diaphragmatic resections and thoracic chemoperfusion on outcomes of peritoneal surface disease treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
|
|
Academic Article
|
Outcomes with cytoreductive surgery and HIPEC for peritoneal metastasis.
|
|
Academic Article
|
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in sarcomatosis from gastrointestinal stromal tumor.
|
|
Academic Article
|
Peritoneal surface disease (PSD) from appendiceal cancer treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): overview of 481 cases.
|
|
Academic Article
|
Significance of diabetes on morbidity and mortality following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
|
|
Academic Article
|
Appendiceal goblet cell carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
|
|
Academic Article
|
Consensus guidelines from The American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States.
|
|
Academic Article
|
Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei.
|
|
Academic Article
|
An assessment of feeding jejunostomy tube placement at the time of resection for gastric adenocarcinoma: A seven-institution analysis of 837 patients from the U.S. gastric cancer collaborative.
|
|
Academic Article
|
Is the Combination of Distal Pancreatectomy and Cytoreductive Surgery With HIPEC Reasonable?: Results of an International Multicenter Study.
|
|
Academic Article
|
Stoma Creation and Reversal After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.
|
|
Academic Article
|
Conditional Survival After Cytoreductive Surgery with Heated Intraperitoneal Chemotherapy for Low- and High-Grade Appendiceal Primaries.
|
|
Academic Article
|
Peritoneal dissemination from high-grade appendiceal cancer treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
|
|
Academic Article
|
Repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: review of indications and outcomes.
|
|
Academic Article
|
Outcomes of Adjuvant Mitotane after Resection of Adrenocortical Carcinoma: A 13-Institution Study by the US Adrenocortical Carcinoma Group.
|
|
Academic Article
|
Routine Admission to Intensive Care Unit After Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy: Not Always a Requirement.
|
|
Academic Article
|
Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma.
|
|
Academic Article
|
Quality-of-Life Evaluation After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.
|
|
Academic Article
|
The American Society of Peritoneal Surface Malignancies Multi-Institution evaluation of 1,051 advanced ovarian cancer patients undergoing cytoreductive surgery and HIPEC: An introduction of the peritoneal surface disease severity score.
|
|
Academic Article
|
Prognostic Factors and Significance of Gastrointestinal Leak After Cytoreductive Surgery (CRS) with Heated Intraperitoneal Chemotherapy (HIPEC).
|
|
Grant
|
PET IN MULTIMODALITY THERAPY FOR ESOPHAGEAL CANCER
|
|
Academic Article
|
Impact of lymph node ratio in selecting patients with resected gastric cancer for adjuvant therapy.
|
|
Academic Article
|
Interval between cytoreductions as a marker of tumor biology in selecting patients for repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
|
|
Academic Article
|
Predictors and Prognostic Implications of Perioperative Chemotherapy Completion in Gastric Cancer.
|
|
Academic Article
|
Frailty Correlates with Postoperative Mortality and Major Morbidity After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.
|
|
Academic Article
|
Outcomes of Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients Older than 70 Years; Survival Benefit at Considerable Morbidity and Mortality: A Reply.
|
|
Academic Article
|
Is Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Justified for Biphasic Variants of Peritoneal Mesothelioma? Outcomes from the Peritoneal Surface Oncology Group International Registry.
|
|
Academic Article
|
PCI is Not Predictive of Survival After Complete CRS/HIPEC in Peritoneal Dissemination from High-Grade Appendiceal Primaries.
|
|
Academic Article
|
A Multicenter Randomized Trial to Evaluate Hematologic Toxicities after Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin or Mitomycin in Patients with Appendiceal Tumors.
|
|
Academic Article
|
Techniques for Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.
|
|
Academic Article
|
Peritoneal Carcinomatosis of Urachus Origin Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): An International Registry of 36 Patients.
|
|
Academic Article
|
Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases From a Small Bowel Adenocarcinoma: Multi-Institutional Experience.
|
|
Academic Article
|
Iterative cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A multi-institutional experience.
|
|
Academic Article
|
Effect of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy on Quality of Life in Patients with Peritoneal Mesothelioma.
|
|
Academic Article
|
The Role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Appendiceal Tumors and Colorectal Adenocarcinomas.
|
|
Academic Article
|
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: patient selection and special considerations.
|
|
Academic Article
|
Appendiceal Cancer Patient-Specific Tumor Organoid Model for Predicting Chemotherapy Efficacy Prior to Initiation of Treatment: A Feasibility Study.
|
|
Academic Article
|
Outcomes After Adjuvant Hyperthermic Intraperitoneal Chemotherapy for High-Risk Primary Appendiceal Neoplasms After Complete Resection.
|